Related references
Note: Only part of the references are listed.Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer
Emanuela Trenti et al.
CANCER CYTOPATHOLOGY (2020)
A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2020)
Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers
Anouk E. Hentschel et al.
CANCERS (2020)
A two-gene methylation signature for the diagnosis of bladder cancer in urine
Judith Bosschieter et al.
EPIGENOMICS (2019)
Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender matters
Christina U. Koehler et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies
Louise Katrine Larsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer
Emanuela Trenti et al.
CANCER CYTOPATHOLOGY (2019)
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
David D'Andrea et al.
BJU INTERNATIONAL (2019)
Novel urinary biomarkers for the detection of bladder cancer: A systematic review
Wei Shen Tan et al.
CANCER TREATMENT REVIEWS (2018)
The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review
Judith Bosschieter et al.
EPIGENOMICS (2018)
A protocol for urine collection and storage prior to DNA methylation analysis
J. Bosschieter et al.
PLOS ONE (2018)
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Willemien Beukers et al.
JOURNAL OF UROLOGY (2017)
Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer
Wina Verlaat et al.
CLINICAL CANCER RESEARCH (2017)
A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria
Christina M. Dahmcke et al.
EUROPEAN UROLOGY (2016)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
Optimization of HPV DNA detection in urine by improving collection, storage, and extraction
A. Vorsters et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer
Lise M. A. De Strooper et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
DNA methylation-based biomarkers in bladder cancer
Raju Kandimalla et al.
NATURE REVIEWS UROLOGY (2013)
The Importance of Being Grade 3: WHO 1999 Versus WHO 2004 Pathologic Grading
Fredrik Liedberg et al.
EUROPEAN UROLOGY (2012)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
Share Paper
